Related Experiment Video
Updated: May 29, 2026
07:03
A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
Honokiol stimulates osteoblastogenesis by suppressing NF-κB activation
Masayoshi Yamaguchi1, Jack L Arbiser, M Neale Weitzmann
1Emory University School of Medicine, 1329 WMRB, Atlanta, GA 30322, USA.
International Journal of Molecular Medicine
|September 3, 2011
Summary
Honokiol, derived from Magnolia officinalis, promotes osteoblast differentiation and bone formation by suppressing inflammation. This natural compound shows promise as a dual anabolic/anti-catabolic agent for treating osteoporosis.
Area of Science:
- Pharmacology and Traditional Medicine
- Bone Biology and Osteoporosis Research
Background:
- Magnolia officinalis extract contains honokiol, a compound with documented anti-inflammatory and neuroprotective effects.
- Inflammation is linked to bone loss in osteoporosis, and NF-κB pathway modulation is key to bone turnover.
- Previous research indicated honokiol's anti-osteoclastogenic effects, but its impact on osteoblasts was unknown.
Purpose of the Study:
- To investigate the effects of honokiol on osteoblast differentiation and activity.
- To determine if honokiol can serve as a dual anabolic/anti-catabolic agent for osteoporosis.
Main Methods:
- Assessed honokiol's ability to induce in vitro osteoblast differentiation.
- Investigated honokiol's effect on NF-κB activation, both basal and TNFα-induced.
- Examined honokiol's influence on BMP-2-induced Smad activation under TNFα suppression.
Main Results:
- Honokiol significantly induced in vitro osteoblast differentiation.
- Honokiol suppressed basal and TNFα-induced NF-κB activation.
- Honokiol alleviated TNFα's suppressive effect on BMP-2-induced Smad activation.
Conclusions:
- Honokiol is a potent inducer of osteoblast differentiation.
- Honokiol demonstrates dual anabolic and anti-catabolic potential for osteoporosis treatment.
- Honokiol warrants further investigation as a therapeutic agent for osteoporotic diseases.
Related Concept Videos
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:21Skeleton and Calcium Homeostasis
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
02:26NF-kB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:25Role of Vitamins in Maintaining Bone Health
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...